Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

NAT-LANTHANUM DIN 02498731

Status: Marketed
Holder: NATCO PHARMA (CANADA) INC
Molecule: LANTHANUM (LANTHANUM CARBONATE DIHYDRATE)
Available to quote

Health Canada record

Active ingredient(s)LANTHANUM (LANTHANUM CARBONATE DIHYDRATE) 250 MG
Dosage formTablet (Chewable)
RouteOral
SchedulePRESCRIPTION
ClassHuman
ATCV03AE03 LANTHANUM CARBONATE
Original market date21-Jul-2020
Current status date21-Jul-2020
SourceHealth Canada DPD

Establishment licence of the holder

Natco Pharma (Canada) Inc — licence 102058, currently licensed, last inspection rating C (2022-07-26).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing LANTHANUM (LANTHANUM CARBONATE DIHYDRATE)

DINProductCompanyFormStrengthStatus
02498758NAT-LANTHANUMNATCO PHARMA (CANADA) INCTablet (Chewable)LANTHANUM (LANTHANUM CARBONATE DIHYDRATE) 500 MGMarketed
02498766NAT-LANTHANUMNATCO PHARMA (CANADA) INCTablet (Chewable)LANTHANUM (LANTHANUM CARBONATE DIHYDRATE) 750 MGMarketed
02498774NAT-LANTHANUMNATCO PHARMA (CANADA) INCTablet (Chewable)LANTHANUM (LANTHANUM CARBONATE DIHYDRATE) 1000 MGMarketed

Notices of Compliance

NOCDateSubmissionReason
235952020-05-14Abbreviated New Drug Submission (ANDS)
Request a quote for NAT-LANTHANUM

How to read a Canadian DIN record